Historical record - last NADAC effective date: 5/23/2013
This NDC is on FDA's drug shortage list (posted Apr 28, 2023)
Reported reason: Other
Product Information
CARBOPLATIN 150 MG/15 ML VIAL is a generic product labeled by Hospira Inc., priced at $0.9933 per ML under NDC 61703033922. Its NADAC has been published 29 times since Nov 28, 2013.
FDA first approved this application on Oct 14, 2004. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Hospira Inc.NDC
61703033922
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAVENOUS
Effective Date
5/23/2013
Active Ingredients
CARBOPLATINApproval Type
Generic (ANDA)
FDA Application
ANDA076517FDA Approved
10/14/2004
TE Code
AP
On Market Since
10/14/2004
Pharmacological Classes
Price Statistics
The NADAC for CARBOPLATIN 150 MG/15 ML VIAL has been published 29 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9933 per ML |
|---|---|
| All-time high | $0.9933 (Jun 11, 2014) |
| All-time low | $0.9933 (Nov 28, 2013) |
| Median price | $0.9933 |
| Average price | $0.9933 |
| Largest weekly change | 0.0% (Dec 5, 2013) |
| Weeks tracked | 29 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Jun 11, 2014 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARBOPLATIN 150 MG/15 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CARBOPLATIN 150 MG/15 ML VIAL, manufactured by Hospira Inc., is $0.9933 per ML (NDC 61703033922), effective Jun 11, 2014.
How has the price of CARBOPLATIN 150 MG/15 ML VIAL changed over time?
Over the history we have for it, the NADAC for CARBOPLATIN 150 MG/15 ML VIAL has held within roughly two percent of its current level. It has been tracked across 29 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARBOPLATIN 150 MG/15 ML VIAL?
Since Nov 28, 2013, the NADAC for CARBOPLATIN 150 MG/15 ML VIAL has ranged from a low of $0.9933 (Nov 28, 2013) to a high of $0.9933 (Jun 11, 2014), with a median of $0.9933 per ML.
Are there cheaper alternatives to CARBOPLATIN 150 MG/15 ML VIAL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CARBOPLATIN 150 MG/15 ML VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures CARBOPLATIN 150 MG/15 ML VIAL?
CARBOPLATIN 150 MG/15 ML VIAL (NDC 61703033922) is labeled by Hospira Inc., and CMS classifies it as a generic product.
Is CARBOPLATIN 150 MG/15 ML VIAL in shortage?
Yes — NDC 61703033922 is currently listed in FDA's drug shortage database (posted Apr 28, 2023). Reported reason: Other.